Problems exacerbate when patients, doctor falsely believe diagnosis isless serious than it actually is
Recent Povorcitinib 2b Study Shows Improved Repigmentation
The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques
Investigational LEO Pharma IL-22 Receptor Improves EASI Scores in AD
The Cutaneous Connection- Episode 35: QRPs and the Dermatology Practice
POLL: What Topics Did You Most Enjoy at AAD 2023?
Lanolin Named Allergen of the Year